Science and medicine are incredibly amazing. Thanks to modern science and medicine, we now have lifespans far beyond our Dark ...
A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...
The market is primed for growth, driven by innovations in stem cell therapies, gene editing, and tissue engineering ...
New research has identified genetic modifications that may increase the effectiveness of immunotherapy for multiple myeloma, ...
Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene editing that they believe may be safer and more efficient than the common ...
3hon MSN
Bridge recombinases, optimized for human cells, enable massive programmable DNA rearrangements
For decades, gene-editing science has been limited to making small, precise edits to human DNA, akin to correcting typos in ...
News-Medical.Net on MSN
Genetic modification enhances "living drugs" for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...
Previously unmapped sections of the genome explain how cells sense their mechanical environment and could open new paths for ...
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced longer-term follow-up data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results